Skip to main navigation Skip to search Skip to main content

Mepolizumab for treating systemic allergic dermatitis with hypereosinophilia likely secondary to a nickel/cobalt-containing coronary artery stent

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)123-125
Number of pages3
JournalContact Dermatitis
Volume86
Issue number2
DOIs
StatePublished - Feb 2022

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Dermatology

Cite this